A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors.
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors. Haemophilia. 2005 May; 11(3):261-9.